Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Stock analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of Janux Therapeutics in a report issued on Monday, May 13th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.38) per share for the quarter, down from their previous estimate […]
Former FDA leader Woodcock inspires Biotech Sisterhood summit fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Research analysts at Wedbush upped their Q1 2024 earnings per share (EPS) estimates for shares of Janux Therapeutics in a note issued to investors on Tuesday, February 27th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($0.40) for the quarter, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Wedbush issued their FY2028 earnings per share estimates for shares of Janux Therapeutics in a report issued on Tuesday, February 27th. Wedbush analyst R. Driscoll forecasts that the company will post earnings of ($1.45) per share for the year. Wedbush has a “Outperform” rating and a $53.00 […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Analysts at Wedbush issued their FY2028 earnings estimates for shares of Janux Therapeutics in a report issued on Tuesday, February 27th. Wedbush analyst R. Driscoll expects that the company will post earnings per share of ($1.45) for the year. Wedbush has a “Outperform” rating and a $53.00 […]